1. Home
  2. AMPH vs SDHC Comparison

AMPH vs SDHC Comparison

Compare AMPH & SDHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPH
  • SDHC
  • Stock Information
  • Founded
  • AMPH 1996
  • SDHC 2008
  • Country
  • AMPH United States
  • SDHC United States
  • Employees
  • AMPH N/A
  • SDHC N/A
  • Industry
  • AMPH Biotechnology: Pharmaceutical Preparations
  • SDHC
  • Sector
  • AMPH Health Care
  • SDHC
  • Exchange
  • AMPH Nasdaq
  • SDHC Nasdaq
  • Market Cap
  • AMPH 1.1B
  • SDHC 933.4M
  • IPO Year
  • AMPH 2014
  • SDHC 2024
  • Fundamental
  • Price
  • AMPH $23.71
  • SDHC $18.03
  • Analyst Decision
  • AMPH Hold
  • SDHC Hold
  • Analyst Count
  • AMPH 5
  • SDHC 4
  • Target Price
  • AMPH $38.00
  • SDHC $23.63
  • AVG Volume (30 Days)
  • AMPH 466.2K
  • SDHC 108.6K
  • Earning Date
  • AMPH 08-06-2025
  • SDHC 08-13-2025
  • Dividend Yield
  • AMPH N/A
  • SDHC N/A
  • EPS Growth
  • AMPH N/A
  • SDHC N/A
  • EPS
  • AMPH 2.77
  • SDHC 0.24
  • Revenue
  • AMPH $730,659,000.00
  • SDHC $1,010,976,000.00
  • Revenue This Year
  • AMPH $0.67
  • SDHC $3.34
  • Revenue Next Year
  • AMPH $5.18
  • SDHC $10.22
  • P/E Ratio
  • AMPH $8.48
  • SDHC $74.91
  • Revenue Growth
  • AMPH 8.05
  • SDHC 28.67
  • 52 Week Low
  • AMPH $22.64
  • SDHC $16.28
  • 52 Week High
  • AMPH $53.96
  • SDHC $39.50
  • Technical
  • Relative Strength Index (RSI)
  • AMPH 40.92
  • SDHC 45.37
  • Support Level
  • AMPH $24.35
  • SDHC $18.01
  • Resistance Level
  • AMPH $25.04
  • SDHC $18.87
  • Average True Range (ATR)
  • AMPH 0.66
  • SDHC 0.97
  • MACD
  • AMPH -0.22
  • SDHC -0.08
  • Stochastic Oscillator
  • AMPH 7.55
  • SDHC 15.73

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

About SDHC Smith Douglas Homes Corp.

Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.

Share on Social Networks: